Parnassus Investments
Parnassus Endeavor Fund
Parnassus Endeavor Fund CME Group Inc stake
total: 118
Parnassus Endeavor Fund CME trades
- Total transactions:
- 9
- New positions:
- 1
- Added:
- 4
- Reduced:
- 4
- Held since:
- 2023 Q1
- Held for:
- 14 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Parnassus Endeavor Fund holds 345,432 CME Group Inc (CME) shares with a market value of roughly $76.28M accounting for 1.44% of the overall portfolio. To date, the estimated cost basis is nearly $196.22 for "buy" trades and estimated average "sell" price is $260.01. Parnassus Endeavor Fund first purchased CME in 2023 Q1, initially acquiring 169,694 shares. Since the initial investment in CME Group Inc (CME), Parnassus Endeavor Fund has made 8 more transactions.
When did Parnassus Endeavor Fund buy CME Group Inc (CME)?
Parnassus Endeavor Fund first invested in CME Group Inc (CME) in 2023 Q1 at the reported quarter-end price of $191.52 per share.
What's the cost basis of Parnassus Endeavor Fund's CME stake?
The estimated cost basis for CME Group Inc (CME) stake is around $196.22 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $196.22
- Weighted AVG sell price:
- $260.01
Parnassus Endeavor Fund's historical trades in CME Group Inc
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.44%
|
345,432
|
$220.83
|
$76,281,749
|
-2.19% (-7,726)
|
-0.04%
|
|
2026 Q1
|
2.26%
|
353,158
|
$295.35
|
$104,305,215
|
-0.04% (-150)
|
-0%
|
|
2025 Q4
|
2.02%
|
353,308
|
$273.08
|
$96,481,349
|
+1.89% (+6,564)
|
+0.04%
|
|
2025 Q3
|
1.99%
|
346,744
|
$270.19
|
$93,686,761
|
+10.38% (+32,606)
|
+0.19%
|
|
2025 Q2
|
1.91%
|
314,138
|
$275.62
|
$86,582,716
|
-0.58% (-1,841)
|
-0.01%
|
|
2025 Q1
|
1.87%
|
315,979
|
$265.29
|
$83,826,069
|
-13.86% (-50,848)
|
-0.28%
|
|
2024 Q3
|
1.60%
|
366,827
|
$220.65
|
$80,940,378
|
+0.26% (+968)
|
+0%
|
|
2023 Q2
|
1.45%
|
365,859
|
$185.29
|
$67,790,014
|
+115.60% (+196,165)
|
+0.78%
|
|
2023 Q1
|
0.70%
|
169,694
|
$191.52
|
$32,499,795
|
new
|
+0.7%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.